Loading Events

« All Events

  • This event has passed.

Elizabeth Blackwell Annual Public Lecture 2020: Genomics and personalised medicine

November 30 2020 @ 1:30 PM - 2:30 PM

The University of Bristol are hosting their annual Elizabeth Blackwell Public Lecture on the topic of Genomics and Healthcare – New opportunities. The lecture this year will be presented by Professor Dame Sue Hill, Chief Scientific Officer for NHS England and Senior Responsible Officer for Genomics in NHS England and NHS Improvement.

Professor Dame Sue Hill discusses the strides being made to embed genomics into the NHS in England through the NHS Genomic Medicine Service, the power and potential of personalised medicine and how genomics is already having a positive impact on the lives of patients and their families.

Please visit the University of Bristol website more information and to register for the event.

Details

Date:
November 30 2020
Time:
1:30 PM - 2:30 PM
Event Categories:
, ,
Event Tags:
, ,
Website:
http://www.bristol.ac.uk/blackwell/events/2020/apl-2020.html

Venue

Online
United Kingdom
With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
 
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
 
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
 
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.